Подписаться
Florian Posch
Florian Posch
MD PhD MSc, Medical University of Graz, Austria
Подтвержден адрес электронной почты в домене medunigraz.at
Название
Процитировано
Процитировано
Год
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
4592019
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
I Pabinger, N van Es, G Heinze, F Posch, J Riedl, EM Reitter, M Di Nisio, ...
The Lancet Haematology 5 (7), e289-e298, 2018
2932018
Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants
F Posch, O Königsbrügge, C Zielinski, I Pabinger, C Ay
Thrombosis research 136 (3), 582-589, 2015
2472015
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
F Posch, K Silina, S Leibl, A Mündlein, H Moch, A Siebenhüner, ...
Oncoimmunology 7 (2), e1378844, 2018
2372018
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients
LM Mauracher, F Posch, K Martinod, E Grilz, T Däullary, L Hell, C Brostjan, ...
Journal of Thrombosis and Haemostasis 16 (3), 508-518, 2018
2312018
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
J Riedl, M Preusser, PMS Nazari, F Posch, S Panzer, C Marosi, P Birner, ...
Blood, The Journal of the American Society of Hematology 129 (13), 1831-1839, 2017
2112017
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ...
The Lancet Oncology 23 (7), e334-e347, 2022
2102022
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
E Grilz, O Königsbrügge, F Posch, M Schmidinger, R Pirker, IM Lang, ...
Haematologica 103 (9), 1549, 2018
1182018
Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality
J Riedl, F Posch, O Königsbrügge, F Lötsch, EM Reitter, E Eigenbauer, ...
PloS one 9 (10), e111440, 2014
992014
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer
E Grilz, LM Mauracher, F Posch, O Königsbrügge, S Zöchbauer‐Müller, ...
British journal of haematology 186 (2), 311-320, 2019
972019
Single-stage revision for the infected total knee replacement: results from a single centre
S Tibrewal, F Malagelada, L Jeyaseelan, F Posch, G Scott
The bone & joint journal 96 (6), 759-764, 2014
962014
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer—a nationwide analysis
E Grilz, F Posch, S Nopp, O Königsbrügge, IM Lang, P Klimek, S Thurner, ...
European Heart Journal 42 (23), 2299-2307, 2021
912021
Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized …
F Moik, F Posch, C Zielinski, I Pabinger, C Ay
Research and practice in thrombosis and haemostasis 4 (4), 550-561, 2020
912020
Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients
O Königsbrügge, F Posch, J Riedl, EM Reitter, C Zielinski, I Pabinger, ...
The oncologist 21 (2), 252-257, 2016
852016
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
S Hatzl, AC Reisinger, F Posch, J Prattes, M Stradner, S Pilz, P Eller, ...
Critical Care 25, 1-11, 2021
812021
Trends and economic impact of hip and knee arthroplasty in Central Europe: findings from the Austrian National Database
L Leitner, S Türk, M Heidinger, B Stöckl, F Posch, W Maurer-Ertl, ...
Scientific reports 8 (1), 4707, 2018
802018
Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
C Ay, F Posch, A Kaider, C Zielinski, I Pabinger
Journal of Thrombosis and Haemostasis 13 (3), 390-397, 2015
802015
The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: a multicentre study
MA Smolle, PU Tunn, E Goldenitsch, F Posch, J Szkandera, M Bergovec, ...
Annals of surgical oncology 24, 1596-1605, 2017
782017
Hypercoagulabilty, venous thromboembolism, and death in patients with cancer
F Posch, J Riedl, EM Reitter, A Kaider, C Zielinski, I Pabinger, C Ay
Thrombosis and haemostasis 115 (04), 817-826, 2016
772016
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
J Gebhart, F Posch, S Koder, T Perkmann, P Quehenberger, C Zoghlami, ...
Blood, The Journal of the American Society of Hematology 125 (22), 3477-3483, 2015
742015
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20